Accelrys, Inc., a US-based provider of scientific innovation lifecycle management software, has announced the new integrated Accelrys Process Management and Compliance Suite of software products designed specifically to enhance product and process insight, facilitate collaboration and streamline product development from research through late-stage quality control and manufacturing. By improving the way businesses manage the scientific innovation lifecycle, the suite helps bring products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.
The Accelrys Process Management and Compliance Suite directly integrates with systems critical to development and manufacturing processes such as laboratory information management systems (LIMS), enterprise resource planning (ERP), product lifecycle management (PLM) and manufacturing execution systems (MES). The ability to leverage existing applications and infrastructure, combined with the features of the Accelrys Process Management and Compliance Suite, offers organisations for the first time a single, unified source for harmonising critical-path data and meeting the ‘right-first-time’ needs of downstream manufacturing. The insights gained from the suite enhance reporting, decision making, knowledge management and operational excellence from lab to commercialisation.
The Accelrys Process Management and Compliance Suite is the result of Accelrys' 2012 acquisition of VelQuest Corporation with its industry-leading paperless lab execution and data capture technology. The integrated suite comprises Accelrys Enterprise Platform; Accelrys Lab Execution System; Accelrys Electronic Lab Notebook (formerly Symyx Notebook by Accelrys); and Accelrys Electronic Batch Records.
Integration of the Accelrys Process Management and Compliance Suite with the Accelrys Enterprise Platform enables lifecycle aggregation, analytics and comprehensive reporting across the continuum from discovery to manufacturing, supporting Six Sigma and Quality by Design (QbD) programs and International Conference on Harmonization (ICH) initiatives in pharmacovigilance and risk management.
